News & Updates

Show Multimedia Only

Baloxavir shows promise in patients with nonsevere influenza

20 Feb 2025

In the treatment of patients with nonsevere influenza virus infection, baloxavir may reduce the risk of hospital admission and shorten the time to symptom relief, according to the results of a systematic review and meta-analysis.

Baloxavir shows promise in patients with nonsevere influenza

20 Feb 2025

Neoadjuvant docetaxel, radiotherapy feasible in high-risk prostate cancer

20 Feb 2025

Neoadjuvant radiation therapy and docetaxel prior to prostatectomy in men with localized high-risk prostate cancer has a modest toxicity profile and results in reasonable long-term outcomes, but pathologic complete response (pCR) is not achieved, results of a phase I/II trial have shown.

Neoadjuvant docetaxel, radiotherapy feasible in high-risk prostate cancer

20 Feb 2025

Postpartum diuretics use eases persistent hypertension

20 Feb 2025 by

The postpartum use of diuretics can reduce persistent hypertension in women with hypertensive disorders of pregnancy (HDP), according to the results of a systematic review and meta-analysis presented at SMFM 2025.

Postpartum diuretics use eases persistent hypertension

20 Feb 2025

MC4R agonist for obesity in young children scores high in phase III trial

20 Feb 2025

The melanocortin-4 receptor (MC4R) agonist setmelanotide demonstrates efficacy in the management of obesity in children younger than 6 years, according to the results of a phase III trial.